Search

Author/Creator Mizutani, Haruko

1. A phase 3, multicenter, randomized, double‐blind, vehicle‐controlled, parallel‐group study of 5% sofpironium bromide (BBI‐4000) gel in Japanese patients with primary axillary hyperhidrosis. Issue 3 (7th January 2021)

Authors:
Yokozeki, Hiroo; Fujimoto, Tomoko; Abe, Yoichiro; Igarashi, Masaru; Ishikoh, Akiko; Omi, Tokuya; Kanda, Hiroki; Kitahara, Hiroto; Kinoshita, Miwako; Nakasu, Ichiro; Hattori, Naoko; Horiuchi, Yuki; Maruyama, Ryuji; Mizutani, Haruko; Murakami, Yoshiyuki; Watanabe, Chiharu; Kume, Akihiro; Hanafusa, ...
Journal:
Journal of dermatology
Issue:
Volume 48:Issue 3(2021)
Page Start:
279
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. A phase III, 52‐week, open‐label study to evaluate the safety and efficacy of 5% sofpironium bromide (BBI‐4000) gel in Japanese patients with primary axillary hyperhidrosis. Issue 8 (26th May 2021)

Authors:
Fujimoto, Tomoko; Abe, Yoichiro; Igarashi, Masaru; Ishikoh, Akiko; Omi, Tokuya; Kanda, Hiroki; Kitahara, Hiroto; Kinoshita, Miwako; Nakasu, Ichiro; Hattori, Naoko; Horiuchi, Yuki; Maruyama, Ryuji; Mizutani, Haruko; Murakami, Yoshiyuki; Watanabe, Chiharu; Kume, Akihiro; Hanafusa, Takaaki; Hamaguch...
Journal:
Journal of dermatology
Issue:
Volume 48:Issue 8(2021)
Page Start:
1149
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search